Viewing Study NCT05354557


Ignite Creation Date: 2025-12-24 @ 6:36 PM
Ignite Modification Date: 2026-01-29 @ 9:16 PM
Study NCT ID: NCT05354557
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-05-18
First Post: 2022-04-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Iberdomide in People With Multiple Myeloma Who Have Had an Autologous Hematopoietic Stem Cell Transplant (AHCT)
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None multiple myeloma View
None Autologous Hematopoietic Stem Cell Transplant View
None Stem Cell Transplant View
None AHCT View
None Iberdomide View
None 22-040 View
None Memorial Sloan Kettering Cancer Center View